Satori Pharmaceuticals, Inc. Garners $22,000,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3eda3b6-367b-49f5-bff6-665723e398bd&Preview=1 - Date
1/8/2009 - Company Name
Satori Pharmaceuticals, Inc. - Mailing Address
222 Berkeley Street Boston, MA 02116 - Company Description
Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders. - Website
http://www.satoripharma.com - Transaction Type
Venture Equity - Transaction Amount
$22,000,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. - M&A Terms
- Venture Investor
InterWest Partners - Venture Investor
Prospect Venture Partners - Venture Investor
New Enterprise Associates - Venture Investor
PureTech Ventures
